HK75195A - Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form - Google Patents

Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form

Info

Publication number
HK75195A
HK75195A HK75195A HK75195A HK75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A
Authority
HK
Hong Kong
Prior art keywords
polypeptide
superoxide dismutase
analog
mutant
recovering
Prior art date
Application number
HK75195A
Other languages
English (en)
Inventor
R Hartman Jacob
Back Yaffa
Original Assignee
Bio-Technology General Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio-Technology General Corporation filed Critical Bio-Technology General Corporation
Publication of HK75195A publication Critical patent/HK75195A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK75195A 1985-11-22 1995-05-18 Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form HK75195A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (1)

Publication Number Publication Date
HK75195A true HK75195A (en) 1995-05-26

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
HK75195A HK75195A (en) 1985-11-22 1995-05-18 Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form

Country Status (21)

Country Link
JP (2) JP2609449B2 (enExample)
AT (1) AT400443B (enExample)
AU (1) AU607897B2 (enExample)
BE (1) BE905796A (enExample)
CA (1) CA1341362C (enExample)
CH (1) CH676990A5 (enExample)
DE (1) DE3639725C2 (enExample)
DK (1) DK534686A (enExample)
ES (1) ES2003518A6 (enExample)
FI (1) FI90353C (enExample)
FR (1) FR2590591B1 (enExample)
GB (1) GB2183658B (enExample)
GR (1) GR862713B (enExample)
HK (1) HK75195A (enExample)
IE (1) IE59498B1 (enExample)
IL (2) IL106449A (enExample)
IT (1) IT1205418B (enExample)
LU (1) LU86676A1 (enExample)
NL (1) NL8602960A (enExample)
PT (1) PT83792B (enExample)
SE (1) SE8604884L (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
JPH0643341B2 (ja) * 1986-03-27 1994-06-08 宇部興産株式会社 臓器機能改善剤
JPH0643340B2 (ja) * 1986-09-03 1994-06-08 宇部興産株式会社 虚血性心疾患治療薬
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
ES2083357T3 (es) * 1987-03-14 1996-04-16 Boehringer Ingelheim Int Manganeso-superoxido-dismutasa humana (hmn-sod).
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
DE3854678T2 (de) * 1987-03-27 1996-06-13 Bio Technology General Corp Menschliches Mangansuperoxiddismutase und Behandlungsverfahren.
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
DE59310242D1 (de) * 1992-09-09 2002-01-17 Bio Technology General Corp Verwendung von Mangan-Superoxiddismutase (Mn-SOD) zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen in niedriger Dosierung
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
WO2025178510A1 (ru) * 2024-02-21 2025-08-28 Евгений Владимирович ГРИГОРЬЕВ Способ применения супероксиддисмутазы 2 в качестве антиоксиданта в сверхмалых дозировках

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
DE3486452T2 (de) * 1983-10-03 1997-11-06 Chiron Corp., Emeryville, Calif. Superoxiddismutase und deren Expression in Mikroorganismen

Also Published As

Publication number Publication date
ATA308986A (de) 1995-05-15
IL106449A (en) 1997-02-18
IL106449A0 (en) 1993-11-15
CH676990A5 (enExample) 1991-03-28
JP2609449B2 (ja) 1997-05-14
SE8604884D0 (sv) 1986-11-14
FI864756A7 (fi) 1987-05-23
FR2590591B1 (fr) 1989-12-01
SE8604884L (sv) 1987-05-23
IT8667865A0 (it) 1986-11-21
DE3639725C2 (de) 1998-02-19
GB2183658A (en) 1987-06-10
GB8627294D0 (en) 1986-12-17
FI90353B (fi) 1993-10-15
IE59498B1 (en) 1994-03-09
AT400443B (de) 1995-12-27
AU607897B2 (en) 1991-03-21
PT83792A (en) 1986-12-01
DK534686D0 (da) 1986-11-07
NL8602960A (nl) 1987-06-16
PT83792B (pt) 1989-01-17
JPS62289187A (ja) 1987-12-16
CA1341362C (en) 2002-05-28
FI864756A0 (fi) 1986-11-21
IE862851L (en) 1987-05-22
LU86676A1 (fr) 1987-05-04
GB2183658B (en) 1990-04-25
GR862713B (en) 1987-03-24
DK534686A (da) 1987-05-23
FR2590591A1 (fr) 1987-05-29
JP2967557B2 (ja) 1999-10-25
IL80702A0 (en) 1987-02-27
FI90353C (fi) 1994-01-25
JPH08289792A (ja) 1996-11-05
IT1205418B (it) 1989-03-15
ES2003518A6 (es) 1988-11-01
AU6497586A (en) 1987-05-28
BE905796A (fr) 1987-03-16
DE3639725A1 (de) 1987-07-23

Similar Documents

Publication Publication Date Title
ES2003518A6 (es) Un metodo de produccion del polipeptido de superoxido dismutasa de manganeso humana o un analogo o un mutante de este
Mathieu et al. Cloning, sequencing and expression in Escherichia coli of the rubredoxin gene from Clostridium pasteurianum
IE960190L (en) Human manganese superoxide dismutase (hMn-SOD)
JPS6485084A (en) Constellation of protein c
EP0861894A4 (en) POLYPEPTIDE THAT SUPPRESSES DIFFERENTIATION
CA2400295A1 (en) Modified factor viii
US4742004A (en) Method for producing enzymatically active eucaryotic sod in bacteria
WO1998046781A3 (en) Novel transgene expression system for increased persistence
Sanbongi et al. Cloning, nucleotide sequence and expression of the cytochrome c‐552 gene from Hydrogenobacter thermophilus
Orth et al. Characterization of a cDNA encoding a manganese peroxidase from Phanerochaete chrysosporium: genomic organization of lignin and manganese peroxidase-encoding genes
Saraste et al. A gene in Paracoccus for subunit III of cytochrome oxidase
CA2131161C (en) Production of aspergillus niger catalase-r
MY130321A (en) Expression vector containing pl promoter and engineered restriction site for convenient replacement of ribosomal binding site, plasmid containing the vectors, hosts containing the plasmids and relatedmethods
Bolgiano et al. Kinetics of the interaction of the cytochrome c oxidase of Paracoccus denitrificans with its own and bovine cytochrome c
WO1998006852A9 (en) Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants
EP0387355A4 (en) Luciferase, luciferase-coding gene, and process for preparing luciferase
Fujinaga et al. Cloning and expression in Escherichia coli of the gene encoding the [2Fe-2S] ferredoxin from Clostridium pasteurianum
HU9203434D0 (en) Biosythetic process for producing chemical products
Saeki et al. Two distinct ferredoxins from Rhodobacter capsulatus: complete amino acid sequences and molecular evolution
EP0336383A3 (en) Novel recombinant human lymphotoxin
CA2304376A1 (en) Dna-construct for the tissue-specific expression of a blood coagulation factor
NZ507563A (en) Gene encoding a protein having activity of transferring sugar onto aurone
DE3707172C2 (de) Rekombiniertes DNA-Molekül, das ein Kreatinasegen codiert, rekombinanter Vektor, der diese DNA-Sequenz umfaßt, sowie Verfahren zur Herstellung von Kreatinase unter Verwendung eines Stammes vom Genus Escherichia, der diesen rekombinanten DNA Vektor enthält
EP0274560A3 (en) Human hematopoietic cell growth potentiating factor
SE9503379D0 (sv) A modified GAD, a method for producing a modified GAD, a method for supplying a modified GAD, a peptide and the use of an ordinary and/or a modified GAD

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)